HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

2,2',3,3',4,5',6,6'-Octabromobiphenyl

HCID 153895
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
119264-60-7
Standard SMILES
Brc1cc(Br)c(-c2c(Br)c(Br)cc(Br)c2Br)c(Br)c1Br
InChIKey
XWEDREXJLOGPJT-UHFFFAOYSA-N
Molecular formula
C12H2Br8
Average molar mass
785.4 g/mol
Monoisotopic mass
777.36234686

Overview

2,2',3,3',4,5,6,6'-Octabromobiphenyl is a polybrominated biphenyl. Polybrominated biphenyls (PBBs) are a group of 209 synthetic organic compounds with 1-10 bromine atoms attached to biphenyl. They can be used as flame retardants and may be added to the plastics used to make products like computer monitors, televisions, textiles, and plastic foams to make them difficult to burn. However, the use of PBBs is banned or restricted in most areas due to their toxicity and persistence in the environment. (L628, L629)

Names & identifiers

Preferred name
2,2',3,3',4,5',6,6'-Octabromobiphenyl
IUPAC
1,2,3,5-tetrabromo-4-(2,3,5,6-tetrabromophenyl)benzene
English name
2,23,34,5,6,6Octabromobiphenyl
Molecular formula
C12H2Br8
Molecular weight
785.37

Names & synonyms

119264-60-72,2',3,3',4,5',6,6'-OctabromobiphenylUNII-5853DG0C6W2,2',3,3',4,5',6,6'-octabromo-1,1'-biphenyl5853DG0C6W1,1'-Biphenyl, 2,2',3,3',4,5',6,6'-octabromo-DTXSID20152373PBB 201RefChem:80545DTXCID30748641,2,3,4-tetrabromo-5-(2,3,5,6-tetrabromophenyl)benzene2,2',3,3',4,5,5',6'-Octabromo-1,1'-biphenyl
Show more names
2,2’3,3’4,5’,6,6’-Octabromo-1,1’-biphenyl2,2',3,3',4,5,6,6'-Octabromobiphenyl,35 ug/mL in isooctane
1,2,3,5-tetrabromo-4-(2,3,5,6-tetrabromophenyl)benzeneNS00126762Q272615562,2',3,3',4,5,6,6'-Octabromobiphenyl,35 ugmL in isooctane

Database identifiers

CAS
119264-60-7
PubChem CID
153895
DTXSID
DTXSID20152373
UNII
5853DG0C6W

Properties

Computed structural propertiesFilling in

XLogP
9.1
Topological polar surface area
0 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
0
Rotatable bonds
1
Heavy atoms
20
Formal charge
0
Complexity
325

Physicochemical properties

Boiling point
511.4 · 511.4±45.0 °C(Predicted)
Density
2.763 · 2.763±0.06 g/cm3(Predicted)
FDA UNII
5853 DG0C6W · 5853DG0C6W
Comptox DTXSID
20152373 · DTXSID20152373

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety & protection

Minimum Risk Level · 2 items

Acute Oral: 0.01 mg/kg/day (L134)

Acute Oral: 0.01 mg/kg/day (L134)

Toxicology

Treatment · 2 items

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

Health Effects · 2 items

PBB exposure may cause weight loss, skin disorders (such as acne), nervous and immune systems effects, and effects on the liver, kidneys, and thyroid gland. (L628)

PBB exposure may cause weight loss, skin disorders (such as acne), nervous and immune systems effects, and effects on the liver, kidneys, and thyroid gland. (L628)

Exposure Routes · 2 items

Oral (L628) ; inhalation (L628) ; dermal (L628)

Oral (L628) ; inhalation (L628) ; dermal (L628)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 2 items

PBBs can be absorbed via oral, inhalation, and dermal routes. Due to their lipophilic nature, PBBs, especially the highly brominated congeners, tend to accumulate in lipid-rich tissues such as the liver, adipose, skin, and breast milk. Certain PBB compounds are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 of the type induced by phenobarbital. The rate of metabolism may depends on the bromine substitution pattern. PBB congeners of low bromine content are transformed into hydroxylated derivatives that are predominately eliminated in the urine. Highly brominated congeners are either retained or excreted unchanged in the feces. (L628)

PBBs can be absorbed via oral, inhalation, and dermal routes. Due to their lipophilic nature, PBBs, especially the highly brominated congeners, tend to accumulate in lipid-rich tissues such as the liver, adipose, skin, and breast milk. Certain PBB compounds are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 of the type induced by phenobarbital. The rate of metabolism may depends on the bromine substitution pattern. PBB congeners of low bromine content are transformed into hydroxylated derivatives that are predominately eliminated in the urine. Highly brominated congeners are either retained or excreted unchanged in the feces. (L628)

Uses & manufacturing

Uses · 2 items

PBBs can be used as flame retardants and may be added to the plastics used to make products like computer monitors, televisions, textiles, and plastic foams to make them difficult to burn. However, the use of PBBs is banned or restricted in most areas due to their toxicity and persistence in the environment. (L628, L629)

PBBs can be used as flame retardants and may be added to the plastics used to make products like computer monitors, televisions, textiles, and plastic foams to make them difficult to burn. However, the use of PBBs is banned or restricted in most areas due to their toxicity and persistence in the environment. (L628, L629)

Applications

2,2’3,3’4,5’,6,6’-Octabromo-1,1’-biphenyl is a polybrominated biphenyls (PBB), used as flame retardants in plastics and textiles industries. It is also used in an assay for the determination of polybrominated biphenols in human milk.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Toxicity Summary · 2 items

The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR). PBBs bind to and activate the AhR, which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. This results in the numerous toxic responses characteristic of PBBs. Some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)

The exact mechanism of toxicty of PBBs varies depending on the specific congener. The predominant interaction is believed to involve the aryl hydrocarbon receptor (AhR). PBBs bind to and activate the AhR, which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. This results in the numerous toxic responses characteristic of PBBs. Some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)

Signs and Symptoms · 2 items

Symptoms of PBB exposure may include nausea, abdominal pain, loss of appetite, joint pain, fatigue, and weakness. (L629)

Symptoms of PBB exposure may include nausea, abdominal pain, loss of appetite, joint pain, fatigue, and weakness. (L629)

Carcinogen Classification · 2 items

2A, probably carcinogenic to humans. (L135)

2A, probably carcinogenic to humans. (L135)

Uses